Skip to main content
OpenTrials

Clinical trial condition

Stage II Breast Cancer AJCC v6 and v7

Explore clinical trials studying Stage II Breast Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

25 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Stage II Breast Cancer AJCC v6 and v7 trial results

Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 744 locations
View Trial Details
Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

NCT02945579

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

NCT01266642

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UF Cancer Center at Orlando Health Orlando, Florida, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

NCT02883062

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +8 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

NCT02954874

Conditions
Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 919 locations
View Trial Details
Active, not recruiting

Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

NCT02912312

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +12 more
Locations
  • MD Anderson Cancer Center (Banner) Gilbert, Arizona, United States
  • Scripps- MD Anderson Cancer San Diego, California, United States
  • MD Anderson Cancer Center (Banner)- Northern Colorado Greeley, Colorado, United States
  • Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States
View Trial Details
Active, not recruiting

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

NCT02276443

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +16 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details
Active, not recruiting

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

NCT03012100

Conditions
Bilateral Breast Carcinoma, Breast Diseases, Breast Inflammatory Carcinoma, +18 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View Trial Details

Related conditions